Evidence map›Paper›PMID 34265233›Full record

Trial reportAmerican journal of respiratory and critical care medicine2021

Dysanapsis and the Spirometric Response to Inhaled Bronchodilators.

Motahareh Vameghestahbanati, Miranda Kirby, François Maltais, Dennis Jensen, Dany Doiron, Wan C Tan, Jean Bourbeau, Benjamin M Smith, CanCOLD Investigators

Abstract readClinical TrialLetter
PubMed Full text at PMC Publisher
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Dysanapsis as a Determinant of Lung Function in Development and Disease.American journal of respiratory and critical care medicine · 2023
    Article
  2. A computed tomography imaging-based subject-specific whole-lung deposition model.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2022
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Motahareh VameghestahbanatiMcGill University Montreal, Quebec, Canada.
Miranda KirbyRyerson University Toronto, Ontario, Canada.
François MaltaisUniversité Laval Quebec City, Quebec, Canada.
Dennis JensenMcGill University Montreal, Quebec, Canada.
Dany DoironMcGill University Montreal, Quebec, Canada.
Wan C TanUniversity of British Columbia Vancouver, British Columbia, Canada.
Jean BourbeauMcGill University Montreal, Quebec, Canada.
Benjamin M SmithMcGill University Montreal, Quebec, Canada.
CanCOLD Investigators

Funding

Chronic obstructive pulmonary disease in non-smokersR01HL130506 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HERBSTMAN, JULIE BETH, SMITH, BENJAMIN M. · 2016 to 2025
$6.3M
Airway Tree Subtyping on Large Cohorts of CT Images for COPD RiskR01HL155816 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LAINE, ANDREW FRANCIS, SMITH, BENJAMIN M. · 2021 to 2024
$2.4M
NHLBI NIH HHS R01 HL130506NHLBI NIH HHS R01 HL155816
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SpirometryAdministration, InhalationAdultAgedAged, 80 and overBronchiBronchodilator AgentsCase-Control StudiesFemaleHumansLinear ModelsLung Volume MeasurementsMaleMiddle AgedOrgan SizePulmonary Disease, Chronic ObstructiveBronchodilator Agents

Identifiers

PMID34265233
PMCPMC8534630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.